Valeant will get a new name — again — hoping to shed its scandals

Valeant Pharmaceuticals International Inc. is hoping that a new name will put a rocky few years and an accounting scandal behind it — again.

The change, to Bausch Health Companies Inc. and the new ticker BHC, is scheduled for July.

It will be the company’s second scandal-inspired name change in less than 10 years. In 2010, after the troubled pharmaceutical company Biovail acquired Valeant VRX, +8.87% the combined company went by the name Valeant instead.

Rebranding is a time-honored tool for companies, giving them a fresh start and bringing them closer to what they want to be known for, said Carreen Winters, chairman of reputation and chief strategy officer at public affairs agency MWWPR.

>>> Original Source <<<